TPM.SG - Tonix Pharmaceuticals Holding Corp

Stuttgart - Stuttgart Delayed price. Currency in EUR
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-108,091
-110,218
-92,287
-50,463
-28,618
Depreciation & amortisation
444
1,253
50
27
26
Stock-based compensation
10,494
10,914
7,899
2,876
1,457
Change in working capital
-1,044
-2
5,781
-2,366
452
Accounts payable
-3,923
-1,045
3,526
1,528
1,663
Other working capital
-167,295
-146,200
-110,864
-57,130
-26,700
Other non-cash items
-
-
3,000
1,360
-
Net cash provided by operating activities
-98,197
-98,053
-75,557
-48,566
-26,683
Cash flows from investing activities
Investments in property, plant and equipment
-69,098
-48,147
-35,307
-8,564
-17
Net cash used for investing activities
-69,098
-48,147
-35,307
-8,564
-17
Cash flows from financing activities
Common stock issued
128,597
94,463
212,389
108,605
5,869
Common stock repurchased
-47,250
-47,250
-
-
-
Other financing activities
-
-
-
107,345
-
Net cash used provided by (used for) financing activities
124,382
87,844
212,487
123,105
12,919
Net change in cash
-42,992
-58,430
101,592
65,959
-13,785
Cash at beginning of period
183,210
178,900
77,308
11,349
25,134
Cash at end of period
140,297
120,470
178,900
77,308
11,349
Free cash flow
Operating cash flow
-98,197
-98,053
-75,557
-48,566
-26,683
Capital expenditure
-69,098
-48,147
-35,307
-8,564
-17
Free cash flow
-167,295
-146,200
-110,864
-57,130
-26,700